# Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer

> **NCT01691040** · PHASE2 · COMPLETED · sponsor: **TME Pharma AG** · enrollment: 12 (actual)

## Conditions studied

- Anemia of Chronic Disease

## Interventions

- **DRUG:** NOX-H94
- **DRUG:** Placebo solution

## Key facts

- **NCT ID:** NCT01691040
- **Lead sponsor:** TME Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01691040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01691040, "Efficacy of NOX-H94 on Anemia of Chronic Disease in Patients With Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01691040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*